Patent directory · USPTO A61K / A61P
Patents matching “TEVA PHARMACEUTICAL INDUSTRIES, LTD.”
302 pharma patents match "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 302 pharmaceutical patents matching "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12310929
Use of rasagiline for the treatment of restless legs syndrome
granted -
US 11472772
S1P3 antagonists
granted -
US 11135154
Medroxyprogesterone acetate injectable compositions and methods of use
granted -
US 10130621
Analogs of pridopidine, their preparation and use
granted -
US 9951017
S1P3 antagonists
granted -
US 9763993
Process for manufacturing glatiramer acetate product
granted -
US 9702007
Genetic markers predictive of response to glatiramer acetate
granted -
US 9687522
Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
granted -
US 9662322
Laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS) patients with a high disability status
granted -
US 9625473
Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
granted -
US 9617596
Biomarkers predictive for clinical response for glatiramer acetate
granted -
US 9585878
Treatment of BDNF-related disorders using laquinimod
granted -
US 9499868
Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate
granted -
US 9409662
Formulations of albu-BChE, preparation and uses thereof
granted -
US 9375403
Formulations of 6-mercaptopurine
granted -
US 9346746
R(+)-N-formyl-propargyl-aminoindan
granted -
US 9339469
R(+)-N-methyl-propargyl-aminoindan
granted -
US 9340307
Stable laquinimod preparations
granted -
US 9308182
Parenteral formulations of rasagiline
granted -
US 9284276
N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof
granted -
US 9233927
Crystals of laquinimod sodium and improved process for the manufacture thereof
granted -
US 9186333
Process for preparing pharmaceutical compositions of fingolimod
granted -
US 9180097
Formulations of 6-mercaptopurine
granted -
US 9161936
Laquinimod for treatment of GABA mediated disorders
granted